PT  - JOURNAL ARTICLE
AU  - Ashley L Lukefahr
AU  - Sean McEvoy
AU  - Chelsea Alfafara
AU  - Janet L Funk
TI  - Drug-induced autoimmune hepatitis associated with turmeric dietary supplement use
AID  - 10.1136/bcr-2018-224611
DP  - 2018 Sep 10
TA  - BMJ Case Reports
PG  - bcr-2018-224611
VI  - 2018
4099  - http://casereports.bmj.com/content/2018/bcr-2018-224611.short
4100  - http://casereports.bmj.com/content/2018/bcr-2018-224611.full
AB  - Turmeric dietary supplement sales, which accounted for US$69 million in spending in 2016, have been increasing exponentially in the USA, making this one of the most popular botanical supplements sold in the USA. Herbal supplement use, which is generally regarded as safe by consumers, is not usually reported to healthcare providers. We reported here on a case of autoimmune hepatitis, occurring in a 71-year-old woman taking turmeric dietary supplements for the maintenance of cardiovascular health, which resolved rapidly following discontinuation of the turmeric supplements. Of particular note, turmeric use was not documented in the patient’s medical records and the potential causative role of the turmeric supplementation was ultimately identified by the patient rather than the healthcare providers. To our knowledge, this is the first documented report of turmeric supplement-induced autoimmune hepatitis.